News of the WeekGene Patents

Patent on HIV Receptor Provokes an Outcry

Science  25 Feb 2000:
Vol. 287, Issue 5457, pp. 1375-1377
DOI: 10.1126/science.287.5457.1375

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

Last week, Human Genome Sciences Inc. (HGS) of Rockville, Maryland, won a U.S. patent on a human gene that plays a key role in HIV infection. The gene codes for a cell surface receptor called CCR5 that HIV uses to gain entry to a cell. But academic scientists who had also chased this gene and, unlike HGS, published scientific papers showing that HIV uses the receptor were dumbfounded--especially because HGS did not know of the AIDS connection when it filed its patent.

Related Content